FR3005409B1 - Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette - Google Patents

Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette

Info

Publication number
FR3005409B1
FR3005409B1 FR1354186A FR1354186A FR3005409B1 FR 3005409 B1 FR3005409 B1 FR 3005409B1 FR 1354186 A FR1354186 A FR 1354186A FR 1354186 A FR1354186 A FR 1354186A FR 3005409 B1 FR3005409 B1 FR 3005409B1
Authority
FR
France
Prior art keywords
silhouette
combat
petroselinic acid
aesthetic disorders
aesthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1354186A
Other languages
English (en)
Other versions
FR3005409A1 (fr
Inventor
Yann Mahe
Carole Bru
Audrey Gueniche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
LOreal SA
Original Assignee
Nestec SA
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1354186A priority Critical patent/FR3005409B1/fr
Application filed by Nestec SA, LOreal SA filed Critical Nestec SA
Priority to PCT/IB2014/061264 priority patent/WO2014181267A1/fr
Priority to US14/890,064 priority patent/US20160074353A1/en
Priority to CN201480038812.3A priority patent/CN105377226B/zh
Priority to CA2911394A priority patent/CA2911394A1/fr
Priority to BR112015027992A priority patent/BR112015027992A2/pt
Priority to EP14726781.9A priority patent/EP2994101A1/fr
Publication of FR3005409A1 publication Critical patent/FR3005409A1/fr
Application granted granted Critical
Publication of FR3005409B1 publication Critical patent/FR3005409B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1354186A 2013-05-07 2013-05-07 Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette Expired - Fee Related FR3005409B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1354186A FR3005409B1 (fr) 2013-05-07 2013-05-07 Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette
US14/890,064 US20160074353A1 (en) 2013-05-07 2014-05-07 Use of petroselinic acid to fight against aesthetic disorders of the body figure
CN201480038812.3A CN105377226B (zh) 2013-05-07 2014-05-07 岩芹酸用以对抗身体体形的审美障碍的用途
CA2911394A CA2911394A1 (fr) 2013-05-07 2014-05-07 Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette
PCT/IB2014/061264 WO2014181267A1 (fr) 2013-05-07 2014-05-07 Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette
BR112015027992A BR112015027992A2 (pt) 2013-05-07 2014-05-07 uso de ácido petroselínico para combater desordens estéticas da figura do corpo
EP14726781.9A EP2994101A1 (fr) 2013-05-07 2014-05-07 Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1354186A FR3005409B1 (fr) 2013-05-07 2013-05-07 Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette

Publications (2)

Publication Number Publication Date
FR3005409A1 FR3005409A1 (fr) 2014-11-14
FR3005409B1 true FR3005409B1 (fr) 2016-08-19

Family

ID=49274744

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1354186A Expired - Fee Related FR3005409B1 (fr) 2013-05-07 2013-05-07 Utilisation d'acide petroselinique pour lutter contre les desordres esthetiques de la silhouette

Country Status (7)

Country Link
US (1) US20160074353A1 (fr)
EP (1) EP2994101A1 (fr)
CN (1) CN105377226B (fr)
BR (1) BR112015027992A2 (fr)
CA (1) CA2911394A1 (fr)
FR (1) FR3005409B1 (fr)
WO (1) WO2014181267A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3030253B1 (fr) * 2014-12-18 2018-03-02 Nutricos Technologies Composition pour ameliorer l'aspect cellulitique de la peau
FR3080769B1 (fr) * 2018-05-04 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Utilisation orale d'huile de graines d'au moins une plante ombellifere pour un effet apaisant des peaux reactives
CN110559222B (zh) * 2019-05-14 2021-11-26 东方爱堡(北京)母婴健康科技有限公司 一种保湿抗氧化凝露及其制备方法
CN111821209B (zh) * 2020-08-20 2023-04-28 中国科学院华南植物园 一种复配型天然美白抗皱组合物和应用
CN115105492B (zh) * 2021-03-17 2023-08-25 南方医科大学南方医院 岩芹酸的新用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725370B1 (fr) * 1994-10-07 1997-06-06 Oreal Composition cosmetique ou dermatologique contenant une huile riche en acide petroselinique
US6262109B1 (en) * 1995-12-22 2001-07-17 Henkel Corporation Methods of preventing and/or treating high serum levels of cholesterol and/or lipids
EP0888773A1 (fr) * 1997-07-05 1999-01-07 Societe Des Produits Nestle S.A. Utilisation de l'acide pétrosélinique pour le traitement des inflammations des tissus superficiels
US20030054015A1 (en) * 2000-12-25 2003-03-20 Shinichiro Haze Sympathetic-activating perfume composition
CA2478663A1 (fr) * 2002-03-11 2003-09-18 General Nutrition Investment Company Procedes de traitement et de prevention d'exces ponderal chez des mammiferes
DE10325159A1 (de) * 2002-06-05 2003-12-18 Grazyna Ziegler-Janoschka Mittel zur äußerlichen Anwendung beim Menschen
JP3769267B2 (ja) * 2002-12-05 2006-04-19 順一 有田 亜鉛増強食品及びその製造方法
JP2005126405A (ja) * 2003-10-25 2005-05-19 Sadami Ishibashi 肥満防止剤
CN101453914A (zh) * 2006-04-13 2009-06-10 凯米迪卡有限公司 治疗代谢功能紊乱的番茄红素
CN101265177A (zh) * 2007-03-16 2008-09-17 中国医学科学院药物研究所 洋芫荽子酸类化合物
FR2952304B1 (fr) * 2009-11-12 2012-01-13 Silab Sa Principe actif cosmetique amincissant issu des fruits de la coriandre et de l'oranger doux, compositions cosmetiques l'incluant et utilisation

Also Published As

Publication number Publication date
CA2911394A1 (fr) 2014-11-13
US20160074353A1 (en) 2016-03-17
EP2994101A1 (fr) 2016-03-16
BR112015027992A2 (pt) 2017-09-12
WO2014181267A1 (fr) 2014-11-13
CN105377226B (zh) 2019-10-25
FR3005409A1 (fr) 2014-11-14
CN105377226A (zh) 2016-03-02

Similar Documents

Publication Publication Date Title
SMT201700130B (it) Diidratodicomposto di benzotiofeneeprocessoper la produzione dello stesso
HK1255605A1 (zh) 新液體組合物的增强的穩定性
EP3024457A4 (fr) Compositions permettant d&#39;améliorer l&#39;avantage thérapeutique du bisantrène
SI2925933T1 (sl) Nove cestne označbe za pomoč pri prepoznavanju okolice vozila
BR302012004277S1 (pt) &#34;configuração aplicada à cápsula&#34;
BR302012004271S1 (pt) &#34;configuração aplicada à cápsula&#34;
DK2838539T3 (da) Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser
BR302012004275S1 (pt) &#34;configuração aplicada à cápsula&#34;
BR302012004276S1 (pt) &#34;configuração aplicada à cápsula&#34;
FR3015290B1 (fr) Compositions d&#39;acide hyaluronique compreant de la mepivacaine
GB201302800D0 (en) Improvements in or relating to the manufacture of variable fluid lenses
BR302012006076S1 (pt) &#34;configuração construtiva aplicada à barbatana&#34;
FR2993882B1 (fr) Procede de preparation d&#39;alkoxyhydroxybenzaldehyde sensiblement exempte d&#39;alkyl-alkoxyhydroxybenzaldehyde
FR3002237B1 (fr) Methodes pour la production de particules virales aav double brin
BR302012004274S1 (pt) &#34;configuração aplicada à cápsula&#34;
FR3005409B1 (fr) Utilisation d&#39;acide petroselinique pour lutter contre les desordres esthetiques de la silhouette
HK1225972A1 (zh) 利用拉喹莫德來延緩亨廷頓氏病的進展
EP2964802A4 (fr) Liaison d&#39;un revêtement de titane à un alliage de cocr coulé
BR302012004273S1 (pt) &#34;configuração aplicada à cápsula&#34;
FR3002723B1 (fr) Kit pour la consommation de drogues solides par inhalation
FR3005408B1 (fr) Utilisation d&#39;acide petroselinique pour lutter contre les desordres esthetiques de la silhouette lies aux modifications du tissu adipeux
FR3006589B1 (fr) Utilisation de propolis pour lutter contre les pathologies associees a l&#39;obesite
FR2980567B1 (fr) Grenade de maintien de l&#39;ordre
BR302012004272S1 (pt) &#34;configuração aplicada à cápsula&#34;
FR3032611B1 (fr) Utilisation de l&#39;acide ellagique pour matifier la peau

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

TQ Partial transmission of property

Owner name: L'OREAL, FR

Effective date: 20190919

Owner name: SOCIETE DES PRODUITS NESTLE S.A., CH

Effective date: 20190919

PLFP Fee payment

Year of fee payment: 8

ST Notification of lapse

Effective date: 20220105